Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1884-1894

  Tate, Michelle D ^a   Brooks, Andrew G ^a   Reading, Patrick C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; GENE MUTATION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG FLUID; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; SITE DIRECTED MUTAGENESIS; VIRUS GENE; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; DOGS; GLYCOSYLATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; MACROPHAGES, ALVEOLAR; MICE; MUTAGENESIS, SITE-DIRECTED; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 80051921486     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100295     Document Type: Article

References (71)

1. Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54: 631-664. (Pubitemid 15073660)
2. Ohuchi, R., M. Ohuchi, W. Garten, and H. D. Klenk. 1997. Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity. J. Virol. 71: 3719-3725. (Pubitemid 27172384)
3. Daniels, R., B. Kurowski, A. E. Johnson, and D. N. Hebert. 2003. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 11: 79-90. (Pubitemid 36126592)
4. Roberts, P. C., W. Garten, and H. D. Klenk. 1993. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J. Virol. 67: 3048-3060. (Pubitemid 23143672)
5. Nobusawa, E., T. Aoyama, H. Kato, Y. Suzuki, Y. Tateno, and K. Nakajima. 1991. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182: 475-485.
6. Wagner, R., T. Wolff, A. Herwig, S. Pleschka, and H. D. Klenk. 2000. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: A study by reverse genetics. J. Virol. 74: 6316-6323. (Pubitemid 30429796)
7. Abe, Y., E. Takashita, K. Sugawara, Y. Matsuzaki, Y. Muraki, and S. Hongo. 2004. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 78: 9605-9611. (Pubitemid 39187078)
8. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69: 531-569.
9. Igarashi, M., K. Ito, H. Kida, and A. Takada. 2008. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology 376: 323-329.
10. Zhang, M., B. Gaschen, W. Blay, B. Foley, N. Haigwood, C. Kuiken, and B. Korber. 2004. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14: 1229-1246. (Pubitemid 39585357)
11. Ohuchi, M., R. Ohuchi, A. Feldmann, and H. D. Klenk. 1997. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 71: 8377-8384. (Pubitemid 27446417)
12. Anders, E. M., C. A. Hartley, and D. C. Jackson. 1990. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. USA 87: 4485-4489. (Pubitemid 20204126)
13. Kawaoka, Y., and R. G. Webster. 1989. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. J. Virol. 63: 3296-3300. (Pubitemid 19181386)
14. Klenk, H. D., R. Wagner, D. Heuer, and T. Wolff. 2002. Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res. 82: 73-75. (Pubitemid 34273715)
15. Hartshorn, K. L., M. R. White, D. R. Voelker, J. Coburn, K. Zaner, and E. C. Crouch. 2000. Mechanism of binding of surfactant protein D to influenza A viruses: Importance of binding to haemagglutinin to antiviral activity. Biochem. J. 351: 449-458.
16. Hartshorn, K. L., M. R. White, V. Shepherd, K. Reid, J. C. Jensenius, and E. C. Crouch. 1997. Mechanisms of anti-influenza activity of surfactant proteins A and D: Comparison with serum collectins. Am. J. Physiol. 273: L1156-L1166.
17. Reading, P. C., L. S. Morey, E. C. Crouch, and E. M. Anders. 1997. Collectin-mediated antiviral host defense of the lung: Evidence from influenza virus infection of mice. J. Virol. 71: 8204-8212. (Pubitemid 27446395)
18. Reading, P. C., J. L. Miller, and E. M. Anders. 2000. Involvement of the mannose receptor in infection of macrophages by influenza virus. J. Virol. 74: 5190-5197. (Pubitemid 30313859)
19. Upham, J. P., D. Pickett, T. Irimura, E. M. Anders, and P. C. Reading. 2010. Macrophage receptors for influenza A virus: Role of the macrophage galactosetype lectin and mannose receptor in viral entry. J. Virol. 84: 3730-3737.
20. Vigerust, D. J., K. B. Ulett, K. L. Boyd, J. Madsen, S. Hawgood, and J. A. McCullers. 2007. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 81: 8593-8600. (Pubitemid 47242833)
21. Hartshorn, K. L., M. R. White, T. Tecle, I. Tornoe, G. L. Sorensen, E. C. Crouch, and U. Holmskov. 2007. Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir. Res. 8: 9.
22. Tate, M. D., A. G. Brooks, and P. C. Reading. 2011. Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection. Immunol. Cell Biol. 89: 482-491.
23. Caton, A. J., G. G. Brownlee, J. W. Yewdell, and W. Gerhard. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427. (Pubitemid 13178866)
24. Reading, P. C., S. Bozza, B. Gilbertson, M. Tate, S. Moretti, E. R. Job, E. C. Crouch, A. G. Brooks, L. E. Brown, B. Bottazzi, et al. 2008. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J. Immunol. 180: 3391-3398.
25. Reading, P. C., P. G. Whitney, D. L. Pickett, M. D. Tate, and A. G. Brooks. 2010. Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. Immunol. Cell Biol. 88: 641-650.
26. Tate, M. D., D. L. Pickett, N. Van Rooijen, A. G. Brooks, and P. C. Reading. 2010. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 84: 7569-7580.
27. Hartley, C. A., D. C. Jackson, and E. M. Anders. 1992. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: Identification of bovine serum beta inhibitor as conglutinin. J. Virol. 66: 4358-4363.
28. Hartshorn, K. L., K. N. Sastry, D. Chang, M. R. White, and E. C. Crouch. 2000. Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L90-L98. (Pubitemid 30104179)
29. Anders, E. M., C. A. Hartley, P. C. Reading, and R. A. Ezekowitz. 1994. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J. Gen. Virol. 75: 615-622. (Pubitemid 24091818)
30. Hoffmann, E., S.Krauss, D. Perez, R.Webby, and R. G.Webster. 2002. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165-3170.
31. Rogers, G. N., and J. C. Paulson. 1983. Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127: 361-373. (Pubitemid 13026446)
32. Tate, M. D., A. G. Brooks, and P. C. Reading. 2008. The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir. Res. 9: 57.
33. Tate, M. D., Y. M. Deng, J. E. Jones, G. P. Anderson, A. G. Brooks, and P. C. Reading. 2009. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 183: 7441-7450.
34. Sur, S., J. S. Wild, B. K. Choudhury, N. Sur, R. Alam, and D. M. Klinman. 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162: 6284-6293. (Pubitemid 29314994)
35. Whitehead, G. S., L. H. Burch, K. G. Berman, C. A. Piantadosi, and D. A. Schwartz. 2006. Genetic basis of murine responses to hyperoxia-induced lung injury. Immunogenetics 58: 793-804. (Pubitemid 44556467)
36. Ayala, A., C. S. Chung, J. L. Lomas, G. Y. Song, L. A. Doughty, S. H. Gregory, W. G. Cioffi, B. W. LeBlanc, J. Reichner, H. H. Simms, and P. S. Grutkoski. 2002. Shock-induced neutrophil mediated priming for acute lung injury in mice: Divergent effects of TLR-4 and TLR-4/FasL deficiency. Am. J. Pathol. 161: 2283-2294. (Pubitemid 35434872)
37. Hartley, C. A., P. C. Reading, A. C. Ward, and E. M. Anders. 1997. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch. Virol. 142: 75-88. (Pubitemid 27050433)
38. Van Eijk, M., M. R. White, J. J. Batenburg, A. B. Vaandrager, L. M. Van Golde, H. P. Haagsman, and K. L. Hartshorn. 2004. Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am. J. Respir. Cell Mol. Biol. 30: 871-879. (Pubitemid 38736912)
39. Bender, B. S., and P. A. Small Jr. 1992. Influenza: Pathogenesis and host defense. Semin. Respir. Infect. 7: 38-45.
40. Reading, P. C., D. L. Pickett, M. D. Tate, P. G. Whitney, E. R. Job, and A. G. Brooks. 2009. Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir. Res. 10: 117.
41. Wells, M. A., P. Albrecht, S. Daniel, and F. A. Ennis. 1978. Host defense mechanisms against influenza virus: Interaction of influenza virus with murine macrophages in vitro. Infect. Immun. 22: 758-762. (Pubitemid 9083962)
42. Tumpey, T. M., A. García-Sastre, J. K. Taubenberger, P. Palese, D. E. Swayne, M. J. Pantin-Jackwood, S. Schultz-Cherry, A. Solórzano, N. Van Rooijen, J.M. Katz, and C. F. Basler. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79: 14933-14944. (Pubitemid 41636290)
43. Engblom, E., T. O. Ekfors, O. H. Meurman, A. Toivanen, and J. Nikoskelainen. 1983. Fatal influenza A myocarditis with isolation of virus from the myocardium. Acta Med. Scand. 213: 75-78. (Pubitemid 13188507)
44. Grose, C., and K. Chokephaibulkit. 2004. Avian influenza virus infection of children in Vietnam and Thailand. Pediatr. Infect. Dis. J. 23: 793-794. (Pubitemid 39063305)
45. Sakamoto, M., F. Suzuki, S. Arai, T. Takishima, and N. Ishida. 1981. Experimental myocarditis induced in mice by infection with influenza A2 virus. Microbiol. Immunol. 25: 173-181. (Pubitemid 11116349)
46. Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73: 5903-5911. (Pubitemid 29274877)
47. Wei, C. J., J. C. Boyington, K. Dai, K. V. Houser, M. B. Pearce, W. P. Kong, Z. Y. Yang, T. M. Tumpey, and G. J. Nabel. 2010. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2: 24ra21.
48. Skehel, J. J., D. J. Stevens, R. S. Daniels, A. R. Douglas, M. Knossow, I. A. Wilson, and D. C. Wiley. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 81: 1779-1783. (Pubitemid 14149547)
49. Wang, H., and C. Jiang. 2009. Avian influenza H5N1: An update on molecular pathogenesis. Sci. China C Life Sci. 52: 459-463.
50. Hartshorn, K. L., R.Webby,M.R.White, T. Tecle,C. Pan, S. Boucher, R. J. Moreland, E. C. Crouch, and R. K. Scheule. 2008. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir. Res. 9: 65.
51. Tate, M. D., E. R. Job, A. G. Brooks, and P. C. Reading. 2011. Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. Virology 413: 84-92.
52. Crouch, E. C., K. Smith, B. McDonald, D. Briner, B. Linders, J. McDonald, U. Holmskov, J. Head, and K. Hartshorn. 2006. Species differences in the carbohydrate binding preferences of surfactant protein D. Am. J. Respir. Cell Mol. Biol. 35: 84-94. (Pubitemid 43993157)
53. Smee, D. F., M. K. Wandersee, M. B. Checketts, B. R. O'Keefe, C. Saucedo, M. R. Boyd, V. P. Mishin, and L. V. Gubareva. 2007. Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor. Antivir. Chem. Chemother. 18: 317-327. (Pubitemid 351448499)
54. Shilov, A. A., and B. V. Sinitsyn. 1994. [Changes in its hemagglutinin during the adaptation of the influenza virus to mice and their role in the acquisition of virulent properties and resistance to serum inhibitors]. Vopr. Virusol. 39: 153-157.
55. Gitelman, A. K., N. V. Kaverin, I. G. Kharitonenkov, I. A. Rudneva, E. L. Sklyanskaya, and V. M. Zhdanov. 1986. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J. Gen. Virol. 67: 2247-2251. (Pubitemid 16026806)
56. Song, M. S., P. N. Pascua, J. H. Lee, Y. H. Baek, O. J. Lee, C. J. Kim, H. Kim, R. J.Webby, R. G.Webster, and Y. K. Choi. 2009. The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J. Virol. 83: 12325-12335.
57. Ping, J., S. K. Dankar, N. E. Forbes, L. Keleta, Y. Zhou, S. Tyler, and E. G. Brown. 2010. PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J. Virol. 84: 10606-10618.
58. Hatta, M., P. Gao, P. Halfmann, and Y. Kawaoka. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842. (Pubitemid 32845783)
59. Zamarin, D., M. B. Ortigoza, and P. Palese. 2006. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J. Virol. 80: 7976-7983. (Pubitemid 44182298)
60. García-Sastre, A., A. Egorov, D. Matassov, S. Brandt, D. E. Levy, J. E. Durbin, P. Palese, and T. Muster. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324-330. (Pubitemid 29013414)
61. Keleta, L., A. Ibricevic, N. V. Bovin, S. L. Brody, and E. G. Brown. 2008. Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2. J. Virol. 82: 11599-11608.
62. Tate, M. D., A. G. Brooks, and P. C. Reading. 2011. Receptor specificity of the influenza virus hemagglutinin modulates sensitivity to soluble collectins of the innate immune system and virulence in mice. Virology 413: 128-138.
63. Louria, D. B., H. L. Blumenfeld, J. T. Ellis, E. D. Kilbourne, and D. E. Rogers. 1959. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J. Clin. Invest. 38: 213-265.
64. Franková, V., and V. Rychterová. 1975. Inhalatory infection of mice with influenza A0/PR8 virus. II. Detection of the virus in the blood and extrapulmonary organs. Acta Virol. 19: 35-40.
65. Taylor, R. M. 1941. Experimental Infection with Influenza a Virus in Mice: The Increase in Intrapulmonary Virus after Inoculation and the Influence of Various Factors Thereon. J. Exp. Med. 73: 43-55.
66. Ning, Z. Y., M. Y. Luo, W. B. Qi, B. Yu, P. R. Jiao, and M. Liao. 2009. Detection of expression of influenza virus receptors in tissues of BALB/c mice by histochemistry. Vet. Res. Commun. 33: 895-903.
67. Glaser, L., G. Conenello, J. Paulson, and P. Palese. 2007. Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Res. 126: 9-18. (Pubitemid 46726689)
68. Job, E. R., Y. M. Deng, M. D. Tate, B. Bottazzi, E. C. Crouch, M. M. Dean, A. Mantovani, A. G. Brooks, and P. C. Reading. 2010. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 185: 4284-4291.
69. Basak, S., D. G. Pritchard, A. S. Bhown, and R.W. Compans. 1981. Glycosylation sites of influenza viral glycoproteins: Characterization of tryptic glycopeptides from the A/USSR(H1N1) hemagglutinin glycoprotein. J. Virol. 37: 549-558. (Pubitemid 11188782)
70. Wang, C. C., J. R. Chen, Y. C. Tseng, C. H. Hsu, Y. F. Hung, S. W. Chen, C. M. Chen, K. H. Khoo, T. J. Cheng, Y. S. Cheng, et al. 2009. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl. Acad. Sci. USA 106: 18137-18142.
71. Tate, M. D., A. G. Brooks, and P. C. Reading. 2011. Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. Microbes Infect. 13: 202-207.